Related new technical papers
CPY* and the power of yeast genetics in the elucidation of quality control and associated protein degradation of the endoplasmic reticulum. Curr Top Microbiol Immunol. 2005;300:41-56 From drug to protein: using yeast genetics for high-throughput target discovery. Curr Opin Chem Biol. 2005 Feb;9(1):20-4 Yeast genetics targets lipids in Parkinson's disease. Trends Genet. 2004 Jul;20(7):273-7 From yeast genetics to biotechnology. Acta Microbiol Immunol Hung. 2002;49(4):483-91 Exploring the catalytic core of complex I by Yarrowia lipolytica yeast genetics. J Bioenerg Biomembr. 2001 Jun;33(3):187-96 Transcription and chromatin converge: lessons from yeast genetics. Curr Opin Genet Dev. 2001 Apr;11(2):142-7 Large-scale mutagenesis: yeast genetics in the genome era. Curr Opin Biotechnol. 2001 Feb;12(1):28-34 Applicability of yeast genetics to neurologic disease. Arch Neurol. 2000 Aug;57(8):1129-34 Impact of yeast genetics and molecular biology on traditional and new biotechnology. Acta Microbiol Immunol Hung. 1999;46(2-3):289-95
| ||||||||||||||||||||||||||||||||||||||